Klaus Haller

[Klaus Haller @HallerKPI]

How will cardiometabolic studies be different post-pandemic? Read on to learn about opportunities for safer, faster trials. https://t.co/WfpgcxQoOp

[Klaus Haller @HallerKPI]

Join @Worldwidetrials Senior Director, Derek Ansel, MS, CCRA, on October 6th where he will participate in the "Expanding the Global Footprint of Pediatric Oncology Trials" discussion at the 2021 PEDS. Register here: https://t.co/WaD1PypfgP https://t.co/oorIoSlQA3

[Klaus Haller @HallerKPI]

Are you considering a non-inferiority study design? A new white paper from Worldwide’s experts will help you build your case. https://t.co/6YHJ2560AZ

[Klaus Haller @HallerKPI]

Thank you to our sponsors for naming @Worldwidetrials a Top Performer in the latest ISR #CRO Quality Benchmarking reports. https://t.co/O3o3C11IGR

[Klaus Haller @HallerKPI]

Meet Mark Bee, our new VP, Business Development for Europe & APAC - one of the many dedicated @Worldwidetrials team members working with passion and purpose every day to improve patient lives! Start your path today ➡ https://t.co/Sd2owUz7kg https://t.co/8u3xXhyySD

[Klaus Haller @HallerKPI]

Innovation is driving development in glioblastoma multiforme therapies. Alaeddin Homsi, MS, BS, discusses the challenges and the opportunities in this short video: https://t.co/k0ina8WqF2 https://t.co/rgbc9wsOLM

[Klaus Haller @HallerKPI]

For 2021, Jeff Trotter has identified some trends to watch for in RWE. But first, how do his 2020 predictions hold up? https://t.co/7mS7p0Ef95

[Klaus Haller @HallerKPI]

Our experts share their perspectives on flexing during COVID-19 to overcome disruptions in the execution of #ALS clinical trials. https://t.co/PeAcuXmVwN

[Klaus Haller @HallerKPI]

This #WorldCancerDay, consider how we, as individuals and as a global community, can change the cancer story for good. #IAmAndIWill @worldwidetrials https://t.co/T5qHdiCfCB

[Klaus Haller @HallerKPI]

Clare joins our growing bench of oncology experts changing the CRO experience. Their search for breakthrough cancer therapies is about more than your trial success - it’s personal. Learn about the team that’s dedicated their life’s work to oncology. https://t.co/7Yt9IMVXk9

[Klaus Haller @HallerKPI]

Is the #505b2 pathway right for your novel therapy? Use @worldwidetrials recent blog post, featuring insights from Camargo, to find out. #UncommonCRO https://t.co/aAcrgcItf0

[Klaus Haller @HallerKPI]

What is the key to success for a #clinicaltrial in a critical care environment? Find out. #UncommonCRO @worldwidetrials https://t.co/qDzvuLRK5x

[Klaus Haller @HallerKPI]

Is your clinical trial struggling? Read our #casestudy about a rescued Phase II study that boosted recruitment, increased site engagement and still achieved an on-time database lock. #UncommonCRO @worldwidetrials https://t.co/WkJrtfTj2j

[Klaus Haller @HallerKPI]

How do you balance and improve the interests of patients, sites & sponsors in a rare disease #clinicaltrial? The #UncommonCRO has answers. #UncommonCRO @worldwidetrials https://t.co/14SqYCsTP9

[Klaus Haller @HallerKPI]

Has your #clinicaltrial program gone astray? A swift intervention is key, and our guide will take you through the process step-by-step. #UncommonCRO @worldwidetrials https://t.co/f3OKxcYdNB

[Klaus Haller @HallerKPI]

Join expert site investigators for our upcoming webinar! Panelists will analyze: - The impact of #COVID19 on conducting trials for novel #oncology therapies - Options for overcoming these challenges And more! Register today: https://t.co/P4P45Y8AbK https://t.co/P31dhaURqg

[Klaus Haller @HallerKPI]

The 2020 CRO Quality Benchmarking Reports are here! Find out which CRO is the best to conduct a given #clinicaltrial. Get the reports. @worldwidetrials https://t.co/kbBwmnw4GR

[Klaus Haller @HallerKPI]

The world of #oncology clinical trials keeps changing. Are you prepared to keep up with it? @worldwidetrials https://t.co/NPYSCndryl

[Klaus Haller @HallerKPI]

While the world of oncology #drugdevelopment is perhaps more complex and competitive than ever, its potential for tremendous patient breakthroughs remains. Do you know how to stay ahead of the curve? @worldwidetrials https://t.co/9wS2c2DogE

[Klaus Haller @HallerKPI]

In @worldwidetrials on-demand webinar, experts discuss how to promote the progress of #orphandisease research. #UncommonCRO https://t.co/R1Yi6xZpT8